MLNT - Melinta Therapeutics Inc.
Previous close
0.5
0 0%
Share volume: 0
Last Updated: Fri 10 Jan 2020 06:00:00 AM CET
Pharmaceuticals: Other:
0%
PREVIOUS CLOSE
CHG
CHG%
$0.50
0.00
0.00%
Summary score
36%
Profitability
50%
Dept financing
17%
Liquidity
19%
Performance
32%
Sector
Health Technology
Industry
Pharmaceuticals: Other
Long-term ratios 30-Sep-2015 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
11.53%
Return on assets
-9.59%
Return on sales
-187.67%
Return on invested capital
88.04%
Total debt ratio
48.39%
Debt ratio change over timeo
-2.54%
Current Ratio
4.99%
Quick Ratio
1.47%
Cash Position Ratio
4.55%
Short-term ratios 30-Sep-2018 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
72.18%
Return on assets
-6.15%
Return on sales
-132.31%
Return on invested capital
155.95%
Total debt ratio
78.44%
Debt ratio change over timeo
-4.89%
Current Ratio
1.18%
Quick Ratio
0.86%
Cash Position Ratio
0.67%
Last quarter ratios 30-Sep-2019
The data are presented for the financials results of the last quarter.
Return on equity
352.52%
Return on assets
-10.27%
Return on sales
-147.8%
Return on invested capital
692.28%
Total debt ratio
126.49%
Debt ratio change over time
-6.29%
Current Ratio
1.03%
Quick Ratio
0.72%
Cash Position Ratio
0.5%
Performance ratios (change over 4 years) 30-Sep-2015 - 30-Sep-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-185.15%
Return on assets
-90.09%
Return on sales
652.54%
Return on invested capital
-248.78%
Total debt ratio
-253.64%
Debt ratio change over time
-2.54%
Current Ratio
-0.33%
Quick Ratio
-4.07%
Cash Position Ratio
0.84%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MLNT | MYOK | MDCO | ARQL |
|---|---|---|---|---|
| Return on equity | 11.53% | -5.44% | -82.7% | -26.35% |
| Return on assets | -9.59% | -4.95% | -6.39% | -11.28% |
| Return on sales | -187.67% | 0% | -592.81% | 0% |
| Return on invested capital | 88.04% | -114.84% | -39.78% | 65.12% |
| Profitability | 50% | 50% | 0% | 18% |
| Total debt ratio | 48.39% | 15.38% | 89.22% | 36.77% |
| Debt ratio change over time | -2.54% | -0.98% | -8.16% | -0.59% |
| Dept financing | 14% | 4% | 25% | 35% |
| Current Ratio | 1.18% | 14.79% | 3.97% | 8.64% |
| Quick Ratio | 0.86% | 0% | 4.55% | 0% |
| Cash Position Ratio | 0.67% | 11.85% | 3.22% | 3.18% |
| Liquididy | 45% | 50% | 41% | 27% |
| Short-term ratios | MLNT | MYOK | MDCO | ARQL |
|---|---|---|---|---|
| Return on equity | 72.18% | -5.63% | 59.24% | -9.46% |
| Return on assets | -6.15% | -5.77% | -5.09% | -7.46% |
| Return on sales | -132.31% | 0% | 0% | 0% |
| Return on invested capital | 155.95% | -95.26% | -20.57% | 51% |
| Profitability | 50% | 0% | 71% | 8% |
| Total debt ratio | 78.44% | 6.35% | 103.58% | 20.64% |
| Debt ratio change over time | -4.89% | -1.07% | -10.63% | -0.73% |
| Dept financing | 19% | 2% | 25% | 30% |
| Current Ratio | 1.18% | 14.79% | 3.97% | 8.64% |
| Quick Ratio | 0.86% | 0% | 4.55% | 0% |
| Cash Position Ratio | 0.67% | 11.85% | 3.22% | 3.18% |
| Liquididy | 8% | 50% | 39% | 21% |